371 related articles for article (PubMed ID: 32151012)
1. Metal Organic Frameworks as Drug Targeting Delivery Vehicles in the Treatment of Cancer.
Cai M; Chen G; Qin L; Qu C; Dong X; Ni J; Yin X
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151012
[No Abstract] [Full Text] [Related]
2. Aperture Modulation of Isoreticular Metal Organic Frameworks for Targeted Antitumor Drug Delivery.
Cai M; Liang W; Wang K; Yin D; Fu T; Zhu R; Qu C; Dong X; Ni J; Yin X
ACS Appl Mater Interfaces; 2022 Aug; 14(32):36366-36378. PubMed ID: 35897121
[TBL] [Abstract][Full Text] [Related]
3. A quest for cytocompatible metal organic frameworks in non-viral gene therapy: Relevance of zeolitic imidazolate framework-8.
Poddar A; Pyreddy S; Polash SA; Doherty CM; Shukla R
Biomater Biosyst; 2022 Dec; 8():100065. PubMed ID: 36824375
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the nanoarchitectonics of metal-organic frameworks for light-activated tumor therapy.
Duan H; Wang F; Xu W; Sheng G; Sun Z; Chu H
Dalton Trans; 2023 Nov; 52(44):16085-16102. PubMed ID: 37814810
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Metal-Organic-Framework-Based Nanocarriers for Controllable Drug Delivery and Release.
Zong Z; Tian G; Wang J; Fan C; Yang F; Guo F
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559283
[TBL] [Abstract][Full Text] [Related]
6. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
Fatima SF; Sabouni R; Garg R; Gomaa H
Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
[TBL] [Abstract][Full Text] [Related]
8. Metal-Organic Framework (MOF)-Based Drug Delivery.
Cao J; Li X; Tian H
Curr Med Chem; 2020; 27(35):5949-5969. PubMed ID: 31215374
[TBL] [Abstract][Full Text] [Related]
9. A juxtaposed review on adsorptive removal of PFAS by metal-organic frameworks (MOFs) with carbon-based materials, ion exchange resins, and polymer adsorbents.
Karbassiyazdi E; Kasula M; Modak S; Pala J; Kalantari M; Altaee A; Esfahani MR; Razmjou A
Chemosphere; 2023 Jan; 311(Pt 1):136933. PubMed ID: 36280122
[TBL] [Abstract][Full Text] [Related]
10. Smart metal organic frameworks: focus on cancer treatment.
Falsafi M; Saljooghi AS; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Biomater Sci; 2021 Mar; 9(5):1503-1529. PubMed ID: 33428697
[TBL] [Abstract][Full Text] [Related]
11. Novel formulations of metal-organic frameworks for controlled drug delivery.
Rao C; Liao D; Pan Y; Zhong Y; Zhang W; Ouyang Q; Nezamzadeh-Ejhieh A; Liu J
Expert Opin Drug Deliv; 2022 Oct; 19(10):1183-1202. PubMed ID: 35426756
[TBL] [Abstract][Full Text] [Related]
12. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
Li B; Ashrafizadeh M; Jiao T
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
[TBL] [Abstract][Full Text] [Related]
13. Advances in the use of MOFs for Cancer Diagnosis and Treatment: An Overview.
Abuçafy MP; da Silva BL; Oshiro-Junior JA; Manaia EB; Chiari-Andréo BG; Armando RAM; Frem RCG; Chiavacci LA
Curr Pharm Des; 2020; 26(33):4174-4184. PubMed ID: 32250216
[TBL] [Abstract][Full Text] [Related]
14. Metal-Organic Framework in Pharmaceutical Drug Delivery.
Kundu S; Swaroop AK; Selvaraj J
Curr Top Med Chem; 2023; 23(13):1155-1170. PubMed ID: 36733193
[TBL] [Abstract][Full Text] [Related]
15. The Progress and Prospect of Zeolitic Imidazolate Frameworks in Cancer Therapy, Antibacterial Activity, and Biomineralization.
Maleki A; Shahbazi MA; Alinezhad V; Santos HA
Adv Healthc Mater; 2020 Jun; 9(12):e2000248. PubMed ID: 32383250
[TBL] [Abstract][Full Text] [Related]
16. Metal-organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics.
Tong PH; Zhu L; Zang Y; Li J; He XP; James TD
Chem Commun (Camb); 2021 Nov; 57(91):12098-12110. PubMed ID: 34714306
[TBL] [Abstract][Full Text] [Related]
17. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
Wei Q; Wu Y; Liu F; Cao J; Liu J
J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
[TBL] [Abstract][Full Text] [Related]
18. Environment Responsive Metal-Organic Frameworks as Drug Delivery System for Tumor Therapy.
Yan C; Jin Y; Zhao C
Nanoscale Res Lett; 2021 Sep; 16(1):140. PubMed ID: 34480260
[TBL] [Abstract][Full Text] [Related]
19. Facile preparation of magnetic metal organic frameworks core-shell nanoparticles for stimuli-responsive drug carrier.
Li S; Bi K; Xiao L; Shi X
Nanotechnology; 2017 Dec; 28(49):495601. PubMed ID: 28985188
[TBL] [Abstract][Full Text] [Related]
20. Applications of Functional Metal-Organic Frameworks in Biosensors.
Du L; Chen W; Zhu P; Tian Y; Chen Y; Wu C
Biotechnol J; 2021 Feb; 16(2):e1900424. PubMed ID: 32271998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
